Form: S-8

Initial registration statement for securities to be offered to employees pursuant to employee benefit plans

April 5, 2023

Documents

Exhibit 107

Calculation of Filing Fee Table

FORM S-8
(Form Type)
 
Ocuphire Pharma, Inc.
(Exact Name of Registrant as Specified in its Charter)

Newly Registered Securities
Security
Type
  
Security Class Title
Fee
Calculation
Rule
  
Amount
Registered
(1)
    
Proposed
Maximum
Offering price
Per Unit
    
Maximum
Aggregate
Offering Price (2)
    
Fee Rate
    
Amount of
Registration
Fee
  
Fees to be
Paid
                                    



Equity
Common Stock,  par value $0.0001 per share, to be issued under the  Ocuphire Pharma, Inc. 2020  Equity Incentive Plan
Other (2)
    
1,043,066
(3)
  
$
3.79
(2)
        
$
0.00011020
        
Total Offering Amounts
                      
$
3,953,220.14
            
$
435.64
  
Total Fees Previously Paid
                                      
$
0.00
  
Total Fee Offsets
                                      
$
0.00
  
Net Fee Due
                                      
$
435.64
  

(1)
Pursuant to Rule 416(a) promulgated under the Securities Act of 1933, as amended, (the “Securities Act”), this Registration Statement shall also cover any additional shares of Ocuphire Pharma, Inc. (the “Registrant”) common stock that become issuable under the Registrant’s 2020 Equity Incentive Plan (the “2020 Plan”) set forth herein by reason of any stock dividend, stock split, reclassification, recapitalization, spin-off or other similar transaction effected without receipt of consideration that increases the number of outstanding shares of Registrant’s common stock, as applicable.
(2)
Estimated solely for the purpose of calculating the amount of the registration fee pursuant to Rule 457(c) and Rule 457(h) under the Securities Act. The offering price per share and aggregate offering price are based on the average of the high and low prices of the Registrant’s common stock as reported on the Nasdaq Capital Market on March 31, 2023.
(3)
Represents 1,043,066 additional shares of Common Stock available for issuance as a result of the annual evergreen increase on January 1, 2023 under the 2020 Plan.